Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Related Citations for PubMed (Select 24049520)

1.

Effect of statins on platelet function in patients with hyperlipidemia.

Sikora J, Kostka B, Marczyk I, Krajewska U, Chałubiński M, Broncel M.

Arch Med Sci. 2013 Aug 30;9(4):622-8. doi: 10.5114/aoms.2013.36905. Epub 2013 Aug 8.

2.

Pravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibition.

Luzak B, Rywaniak J, Stanczyk L, Watala C.

Eur J Clin Invest. 2012 Aug;42(8):864-72. doi: 10.1111/j.1365-2362.2012.02661.x. Epub 2012 Mar 13.

PMID:
22409214
3.

Statins have an early antiplatelet effect in patients with acute myocardial infarction.

Matetzky S, Fefer P, Shenkman B, Shechter M, Novikov I, Savion N, Varon D, Hod H.

Platelets. 2011;22(2):103-10. doi: 10.3109/09537104.2010.512402. Epub 2010 Dec 21.

PMID:
21171935
4.

Not all statins interfere with clopidogrel during antiplatelet therapy.

Mach F, Senouf D, Fontana P, Boehlen F, Reber G, Daali Y, de Moerloose P, Sigwart U.

Eur J Clin Invest. 2005 Aug;35(8):476-81.

PMID:
16101667
5.

The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.

Vinholt P, Poulsen TS, Korsholm L, Kristensen SR, Hallas J, Damkier P, Mickley H.

Thromb Haemost. 2005 Aug;94(2):438-43.

PMID:
16113837
6.

Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients.

Małyszko J, Małyszko JS, Hryszko T, Myśliwiec M.

Am J Nephrol. 2001 Sep-Oct;21(5):373-7.

PMID:
11684797
7.
8.

Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia.

Szapary L, Horvath B, Marton Z, Alexy T, Kesmarky G, Habon T, Szots M, Koltai K, Juricskay I, Czopf J, Toth K.

CNS Drugs. 2004;18(3):165-72.

PMID:
14871160
9.

Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.

Castaño G, Fernández L, Mas R, Illnait J, Mesa M, Fernández JC.

Clin Drug Investig. 2003;23(10):639-50.

PMID:
17535079
10.

Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.

Park Y, Jeong YH, Tantry US, Ahn JH, Kwon TJ, Park JR, Hwang SJ, Gho EH, Bliden KP, Kwak CH, Hwang JY, Kim S, Gurbel PA.

Eur Heart J. 2012 Sep;33(17):2151-62. doi: 10.1093/eurheartj/ehs083. Epub 2012 Apr 16.

11.

[Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].

Pokrovskaia EV, Vaulin NA, Gratsianskiĭ NA, Averkov OV, Deev AD.

Kardiologiia. 2003;43(1):7-18. Russian.

PMID:
12891281
12.

Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease.

Tirnaksiz E, Pamukcu B, Oflaz H, Nisanci Y.

J Thromb Thrombolysis. 2009 Jan;27(1):24-8. Epub 2007 Oct 5.

PMID:
17917708
13.

[Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].

Szapáry L, Horváth B, Márton Z, Fehér G, Tóth K, Komoly S.

Orv Hetil. 2008 Jun 15;149(24):1117-23. doi: 10.1556/OH.2008.28267. Hungarian.

PMID:
18539578
14.

Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.

Joukhadar C, Klein N, Prinz M, Schrolnberger C, Vukovich T, Wolzt M, Schmetterer L, Dorner GT.

Thromb Haemost. 2001 Jan;85(1):47-51.

PMID:
11204586
15.

Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.

Wenaweser P, Windecker S, Billinger M, Cook S, Togni M, Meier B, Haeberli A, Hess OM.

Am J Cardiol. 2007 Feb 1;99(3):353-6. Epub 2006 Dec 14.

PMID:
17261397
16.

Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia.

Stein DT, Devaraj S, Balis D, Adams-Huet B, Jialal I.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2026-31.

17.

Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins.

Rauch U, Osende JI, Chesebro JH, Fuster V, Vorchheimer DA, Harris K, Harris P, Sandler DA, Fallon JT, Jayaraman S, Badimon JJ.

Atherosclerosis. 2000 Nov;153(1):181-9.

PMID:
11058714
18.

Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.

Iwase H, Ekser B, Zhou H, Dons EM, Cooper DK, Ezzelarab MB.

Xenotransplantation. 2012 Jul-Aug;19(4):233-43. doi: 10.1111/j.1399-3089.2012.00712.x.

19.

Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.

Puccetti L, Bruni F, Bova G, Cercignani M, Palazzuoli A, Console E, Auteri A, Pasqui AL.

Nutr Metab Cardiovasc Dis. 2001 Dec;11(6):378-87.

PMID:
12055702
20.

Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?

Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.

J Am Coll Cardiol. 2007 Mar 13;49(10):1035-42. Epub 2007 Feb 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk